Get started
Award

P30 CA015704

Funded outputs count: 381
Funder award ID: P30 CA015704
OpenAlex ID: G1713994812
Functional and acid-stability constraints on the Junin virus glycoprotein complex
2026 · Caleb R. Carr, Colin J. Mann, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Targeted Engineering of Human MxA Yields a Broad-Spectrum Super-Restrictor of Human-Adapted Influenza Viruses
2026 · Megan E. Levy, Rechel A. Geiger, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Evaluating the role of non-HIV antigens in the initiation of QA013.2 HIV bnAb lineage
2026 · Delphine M. Depierreux, Kevin Sung, et al. · Scientific Reports
PDF
Characterization of an immunodeficiency-associated EZH2 variant
2026 · Francisco Perez de los Santos, Lily Beck, et al. · NAR Molecular Medicine
PDF
Dysregulation of epithelial differentiation architecture underlies field cancerization in head and neck cancer
2026 · Claire Mills, Yin Huang, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Reviewer #3 (Public review): RelB proximity proteomics and CRISPR screening define chromatin regulators of noncanonical NF-κB control of HIV latency and reactivation
2026 · eLife
eLife Assessment: RelB proximity proteomics and CRISPR screening define chromatin regulators of noncanonical NF-κB control of HIV latency and reactivation
2026 · Amit Singh · eLife
Author response: RelB proximity proteomics and CRISPR screening define chromatin regulators of noncanonical NF-κB control of HIV latency and reactivation
2026 · Cameron R Bussey-Sutton, Carley N Gray, et al. · eLife
Reviewer #2 (Public review): RelB proximity proteomics and CRISPR screening define chromatin regulators of noncanonical NF-κB control of HIV latency and reactivation
2026 · eLife
Reviewer #1 (Public review): RelB proximity proteomics and CRISPR screening define chromatin regulators of noncanonical NF-κB control of HIV latency and reactivation
2026 · eLife
PDF
RelB proximity proteomics and CRISPR screening define chromatin regulators of noncanonical NF-κB control of HIV latency and reactivation
2026 · Cameron R Bussey-Sutton, Carley N Gray, et al. · eLife
Single-Cell Behavioromics Enables Fate Prediction of Individual Hematopoietic Stem Cells
2026 · Alisa B. Chankhunthod, Rhys Sorenson-Graff, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
tRNA dosage regulates lineage dependency and resistance in prostate cancer
2026 · Yeon Soo Kim, Sonali Arora, et al. · Nature
PDF
Efficacy of Tailored Messages for 28-Week Exercise Sustainability in People with HIV
2026 · Paul F. Cook, Allison R. Webel, et al. · AIDS and Behavior · 1
PDF
Somatic DDX41 mutations confer neomorphic splicing activity in the pathogenesis of myelodysplastic neoplasms
2026 · Rasika Venkataraman, Noemi Puccio, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Mutational constraints on RSV F and its neutralization by antibodies
2026 · Cassandra A. L. Simonich, Teagan E. McMahon, et al. · Nature
Near real-time data on the human neutralizing antibody landscape to influenza virus in summer of 2026 shows antigenic advance of H3N2 subclade K region D mutants and H1N1 D.3.1.1 Sa mutants
2026 · Caroline Kikawa, Andrew Butler, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
ATR inhibition induces NF-κB-dependent immunogenicity in Merkel cell carcinoma independent of cGAS-STING
2026 · Rashmi Bhakuni, Jung Hyun Lee, et al. · npj Precision Oncology
PDF
Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma
2026 · Yuta Asano, Joshua R. Veatch, et al. · Science Translational Medicine
Evaluating an anti-idiotype derived germline-targeting immunogen designed to elicit VRC01-class precursors in human antibody transgenic mice
2026 · Crystal B. Chhan, Yu-Hsin Wan, et al. · mSphere
PDF
A distinct effector B cell population drives autoantibody production in SARS-CoV-2 infection
2026 · Dan Yuan, Sarah Li, et al. · Immunity
PDF
SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer
2026 · Steven Blinka, Sonali Arora, et al. · Clinical Cancer Research
PDF
RelB proximity proteomics and CRISPR screening define chromatin regulators of noncanonical NF-κB control of HIV latency and reactivation
2026 · Cameron R. Bussey-Sutton, Carley N. Gray, et al. · bioRxiv (Cold Spring Harbor Laboratory)
In vivo engineering of T cells with a synthetic cytokine receptor enables selective enrichment and expansion of anti-CD22 CAR T cells
2026 · Travis J. Friesen, Alyssa Sheih, et al. · Molecular Therapy
PDF
Native yeast kinetochore structures identify an essential inner kinetochore interaction
2026 · Mengqiu Jiang, Changkun Hu, et al. · Nature Communications
Year
Topic